Finance

Lists
Outlook: 57.1% bullish·28.6% bearish
Go to analysis
RPID:NASDAQ
Rapid Micro Biosystems, Inc
$0.74
-0.04%
(-0.00030) 1D
$0.73
-0.03% (-0.00020)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RPID...
Open
$0.74
High
$0.74
Low
$0.74
Mkt. cap
37.13M
Avg. vol.
864.85K
Volume
1.45M
52-wk high
$4.94
52-wk low
$0.58
EPS
-$1.11
Beta
1.52
Shares outstanding
46.34M
No. of employees
171
Open
$0.74
High
$0.74
Low
$0.74
Mkt. cap
37.13M
Avg. vol.
864.85K
Volume
1.45M
52-wk high
$4.94
52-wk low
$0.58
EPS
-$1.11
Beta
1.52
Shares outstanding
46.34M
No. of employees
171
News stories
From web sources and news partners
About Rapid Micro Biosystems, Inc
CEO-
Employees171
Founded2006
HeadquartersLowell, Massachusetts, United States
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to RPID in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RPID in the last 3 months.
Highest
Current $0.74
$0.75 (+2.04%)
Average
$0.75 (+2.04%)
Lowest
$0.75 (+2.04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Hold
Downgraded
$0.75
+2%
11/17/2026
Thomas Flaten
Lake Street
Hold
Downgraded
$0.75
+2%
11/16/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
$8.00
+988.4%
08/10/2026
Paul Knight
KeyBanc
Buy
Maintained
$5.00
+580.3%
05/29/2026
Brendan Smith
TD Cowen
Buy
Maintained
-
-
05/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
11.28M
8.00M
8.05M
9.53M
Cost of goods sold
11.61M
7.63M
6.84M
7.13M
Cost of revenue
11.61M
7.63M
6.84M
7.13M
Research and development expenses
3.22M
3.36M
3.33M
2.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.66M
10.86M
10.20M
9.35M
Operating expense
11.88M
14.22M
13.53M
12.32M
Total operating expenses
23.49M
21.85M
20.38M
19.45M
Operating income
-12.21M
-13.85M
-12.32M
-9.92M
Other non operating income
80.00K
-32.00K
-50.00K
-74.00K
EBT including unusual items
-12.48M
-14.27M
-12.88M
-11.25M
EBT excluding unusual items
-12.48M
-14.27M
-12.88M
-10.53M
Income tax expense
14.00K
8.00K
45.00K
21.00K
Effective tax rate
-0.11%
-0.06%
-0.35%
-0.19%
Other operating expenses
-
-
-
-
Net income
-12.50M
-14.28M
-12.92M
-11.27M
Net profit margin
-110.77%
-178.39%
-160.45%
-118.26%
Earnings per share
-0.28
-0.31
-0.27
-0.22
Interest and investment income
321.00K
256.00K
140.00K
98.00K
Interest expense
-673.00K
-639.00K
-646.00K
-632.00K
Net interest expenses
-352.00K
-383.00K
-506.00K
-534.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.62M
-13.15M
-11.65M
-9.24M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps